- XLNX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing
Xilinx (XLNX) 8-KResults of Operations and Financial Condition
Filed: 21 Jan 14, 12:00am
Growth Rates | ||||||
Q3 FY 2014 | Q2 FY 2014 | Q3 FY 2013 | Q-T-Q | Y-T-Y | ||
Net revenues | $586.8 | $598.9 | $509.8 | -2% | 15% | |
Operating income | $202.7 | $163.8 | $120.8 | 24% | 68% | |
Net income | $175.9 | $141.5 | $103.6 | 24% | 70% | |
Diluted earnings per share | $0.61 | $0.49 | $0.38 | 24% | 61% |
Percentages | Growth Rates | |||||
Q3 FY 2014 | Q2 FY 2014 | Q3 FY 2013 | Q-T-Q | Y-T-Y | ||
North America | 29% | 31% | 32% | -9% | 5% | |
Asia Pacific | 40% | 38% | 34% | 3% | 36% | |
Europe | 22% | 22% | 24% | -5% | 4% | |
Japan | 9% | 9% | 10% | 6% | 5% |
Percentages | Growth Rates | |||||
Q3 FY 2014 | Q2 FY 2014 | Q3 FY 2013 | Q-T-Q | Y-T-Y | ||
Communications & Data Center | 44% | 43% | 47% | 0% | 9% | |
Industrial, Aerospace & Defense | 37% | 38% | 36% | -5% | 18% | |
Broadcast, Consumer & Automotive | 16% | 16% | 15% | -3% | 22% | |
Other | 3% | 3% | 2% | 9% | 40% |
Percentages | Growth Rates | |||||
Q3 FY 2014 | Q2 FY 2014 | Q3 FY 2013 | Q-T-Q | Y-T-Y | ||
New | 38% | 36% | 25% | 5% | 79% | |
Mainstream | 33% | 34% | 41% | -5% | -10% | |
Base | 26% | 27% | 30% | -7% | 0% | |
Support | 3% | 3% | 4% | -5% | -7% |
Q3 FY 2014 | Q2 FY 2014 | Q3 FY 2013 | |
Annual Return on Equity (%)* | 20 | 19 | 17 |
Operating Cash Flow | $216 | $255 | $123 |
Depreciation Expense | $14 | $14 | $14 |
Capital Expenditures | $11 | $8 | $8 |
Combined Inventory Days | 114 | 102 | 131 |
Revenue Turns (%) | 52 | 54 | 58 |
• | Xilinx shipped the industry’s first 20nm product in November 2013, continuing to execute on an aggressive rollout of its All Programmable UltraScale™ portfolio. The UltraScale product portfolio delivers the industry’s only ASIC-class programmable architecture and extends Xilinx’s market leading Kintex, and Virtex FPGA and 3D IC families. When combined with Vivado™ and the recently introduced UltraFast™ design methodology, Ultrascale devices enable next generation smarter systems such as 400G OTN, WCDMA Radio, and Intelligence Surveillance and Reconnaissance and high performance computing applications for the data center. |
• | Xilinx announced a record breaking 4.4M logic cell device, more than doubling its industry leading highest capacity Virtex-7 device. This is Xilinx’s second generation Stacked Silicon Interconnect technology built on TSMC’s CoWoS manufacturing technology, enabling Xilinx to deliver devices with 2-4X the capacity of competing devices and continue to stay ahead of what Moore’s Law could otherwise offer. |
• | Sales are expected to be up 2% to up 6% sequentially. |
• | Gross margin is expected to be approximately 68%. |
• | Operating expenses are expected to be approximately $226 million, including $2.5 million of amortization of acquisition-related intangibles. |
• | Other income and expenses are expected to be a net expense of approximately $7 million. |
• | Fully diluted share count is expected to be approximately 289 million. |
• | March quarter tax rate is expected to be approximately 13%. |
Three Months Ended | Nine Months Ended | ||||||||||||||||||
December 28, 2013 | September 28, 2013 | December 29, 2012 | December 28, 2013 | December 29, 2012 | |||||||||||||||
Net revenues | $ | 586,816 | $ | 598,937 | $ | 509,767 | $ | 1,764,708 | $ | 1,636,484 | |||||||||
Cost of revenues | 180,792 | 182,816 | 170,493 | 543,308 | 556,617 | ||||||||||||||
Gross margin | 406,024 | 416,121 | 339,274 | 1,221,400 | 1,079,867 | ||||||||||||||
Operating expenses: | |||||||||||||||||||
Research and development | 128,092 | 125,002 | 129,055 | 364,635 | 364,389 | ||||||||||||||
Selling, general and administrative | 91,794 | 96,339 | 86,823 | 280,520 | 274,952 | ||||||||||||||
Amortization of acquisition-related intangibles | 2,589 | 2,418 | 2,554 | 7,425 | 7,021 | ||||||||||||||
Litigation and contingencies | (19,190 | ) | 28,600 | — | 9,410 | — | |||||||||||||
Total operating expenses | 203,285 | 252,359 | 218,432 | 661,990 | 646,362 | ||||||||||||||
Operating income | 202,739 | 163,762 | 120,842 | 559,410 | 433,505 | ||||||||||||||
Interest and other expense, net | 4,807 | 10,997 | 5,149 | 25,734 | 24,824 | ||||||||||||||
Income before income taxes | 197,932 | 152,765 | 115,693 | 533,676 | 408,681 | ||||||||||||||
Provision for income taxes | 22,055 | 11,304 | 12,045 | 59,315 | 51,765 | ||||||||||||||
Net income | $ | 175,877 | $ | 141,461 | $ | 103,648 | $ | 474,361 | $ | 356,916 | |||||||||
Net income per common share: | |||||||||||||||||||
Basic | $ | 0.66 | $ | 0.53 | $ | 0.40 | $ | 1.78 | $ | 1.36 | |||||||||
Diluted | $ | 0.61 | $ | 0.49 | $ | 0.38 | $ | 1.66 | $ | 1.31 | |||||||||
Cash dividends per common share | $ | 0.25 | $ | 0.25 | $ | 0.22 | $ | 0.75 | $ | 0.66 | |||||||||
Shares used in per share calculations: | |||||||||||||||||||
Basic | 267,780 | 268,478 | 260,690 | 266,068 | 261,723 | ||||||||||||||
Diluted | 288,195 | 290,685 | 271,174 | 285,380 | 271,861 |
December 28, 2013 | March 30, 2013 * | ||||||
(unaudited) | |||||||
ASSETS | |||||||
Current assets: | |||||||
Cash, cash equivalents and short-term investments | $ | 2,457,419 | $ | 1,714,745 | |||
Accounts receivable, net | 207,248 | 229,175 | |||||
Inventories | 206,728 | 201,250 | |||||
Deferred tax assets and other current assets | 76,431 | 152,469 | |||||
Total current assets | 2,947,826 | 2,297,639 | |||||
Net property, plant and equipment | 354,800 | 365,687 | |||||
Long-term investments | 1,287,392 | 1,651,033 | |||||
Other assets | 411,783 | 415,092 | |||||
Total Assets | $ | 5,001,801 | $ | 4,729,451 | |||
LIABILITIES , TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable and accrued liabilities | $ | 309,009 | $ | 333,379 | |||
Deferred income on shipments to distributors | 48,075 | 53,358 | |||||
Deferred tax liabilities | 140,601 | 51 | |||||
Convertible debentures | 934,392 | — | |||||
Total current liabilities | 1,432,077 | 386,788 | |||||
Convertible debentures | — | 922,666 | |||||
Deferred tax liabilities | 279,696 | 415,442 | |||||
Other long-term liabilities | 13,057 | 41,259 | |||||
Temporary equity | 355,243 | — | |||||
Stockholders' equity | 2,921,728 | 2,963,296 | |||||
Total Liabilities, Temporary Equity and Stockholders' Equity | $ | 5,001,801 | $ | 4,729,451 | |||
* Derived from audited financial statements |
Three Months Ended | Nine Months Ended | ||||||||||||||||||
December 28, 2013 | September 28, 2013 | December 29, 2012 | December 28, 2013 | December 29, 2012 | |||||||||||||||
SELECTED CASH FLOW INFORMATION: | |||||||||||||||||||
Depreciation | $ | 13,595 | $ | 13,976 | $ | 13,680 | $ | 41,604 | $ | 42,434 | |||||||||
Amortization | 5,058 | 4,885 | 4,423 | 14,828 | 12,878 | ||||||||||||||
Stock-based compensation | 24,339 | 23,060 | 19,762 | 68,353 | 56,616 | ||||||||||||||
Net cash provided by operating activities | 216,390 | 254,943 | 122,568 | 615,542 | 482,884 | ||||||||||||||
Purchases of property, plant and equipment | 10,975 | 8,441 | 8,075 | 30,717 | 24,053 | ||||||||||||||
Payment of dividends to stockholders | 67,096 | 67,198 | 57,326 | 200,301 | 172,647 | ||||||||||||||
Repurchases of common stock | 97,140 | 69,981 | 19,541 | 167,121 | 197,689 | ||||||||||||||
Proceeds from issuance of common stock to employees and excess tax benefit | 12,729 | 110,925 | 20,547 | 157,611 | 58,201 | ||||||||||||||
STOCK-BASED COMPENSATION INCLUDED IN: | |||||||||||||||||||
Cost of revenues | $ | 1,966 | $ | 1,858 | $ | 1,517 | $ | 5,628 | $ | 4,718 | |||||||||
Research and development | 11,912 | 11,343 | 9,654 | 33,474 | 27,681 | ||||||||||||||
Selling, general and administrative | 10,461 | 9,859 | 8,591 | 29,251 | 24,217 |